Moolec Science SA (MLEC)
NASDAQ: MLEC · Real-Time Price · USD
6.50
+0.03 (0.46%)
At close: Jan 30, 2026, 4:00 PM EST
6.24
-0.26 (-4.00%)
After-hours: Jan 30, 2026, 7:47 PM EST
Moolec Science Revenue
Moolec Science had revenue of $2.64M in the quarter ending December 31, 2024, with 948.32% growth. This brings the company's revenue in the last twelve months to $7.83M, up 170.36% year-over-year. In the fiscal year ending June 30, 2024, Moolec Science had annual revenue of $5.63M with 521.53% growth.
Revenue (ttm)
$7.83M
Revenue Growth
+170.36%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 5.63M | 4.72M | 521.53% |
| Jun 30, 2023 | 905.05K | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GeoVax Labs | 3.35M |
| Xenetic Biosciences | 2.86M |
| Cyclerion Therapeutics | 2.86M |
| 60 Degrees Pharmaceuticals | 1.36M |
| PMGC Holdings | 285.95K |
| Abpro Holdings | 183.00K |
| Silo Pharma | 72.10K |
MLEC News
- 22 hours ago - Moolec Science Granted Continued Listing on Nasdaq Subject to Hearings Panel Conditions - Accesswire
- 7 days ago - Moolec Science S.A. Receives Nasdaq Staff Memo Supporting Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders' Equity Requirement - Accesswire
- 9 days ago - Moolec Science S.A. Receives Nasdaq Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders' Equity Requirement - Accesswire
- 25 days ago - Moolec Science Announces Effectiveness of Share Consolidation - Accesswire
- 4 weeks ago - Moolec Receives Staff Determination Letter and Provides Update on Nasdaq Listing Compliance Status - Accesswire
- 4 weeks ago - Moolec Science SA Announces the Implementation of a Share Consolidation of Its Ordinary Shares, Par Value U.S.$0.10 Per Share (the "Shares") - Accesswire
- 7 weeks ago - Moolec Science Scales GLASO U.S. Platform With Record 2025 Campaign and Expansion Into Nutrition & Supplements Market - Accesswire
- 2 months ago - Moolec Receives Nasdaq Determination Letter - Accesswire